Physician

Alireza Mirmiran, MD

According to 2025 Medicare claims, Alireza Mirmiran, MD (NPI: 1801930441) practices radiation oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is NEBRASKA METHODIST HOSPITAL (NPI: 1689628372; TIN: 470376604) and primary practice location at 68114-4108. Mirmiran is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mirmiran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 226 traditional Medicare patients, billed 1,392 HCPCS/CPT codes, and received $105,498 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 159 prescription claims across 53 beneficiaries totaling $3,178 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). 2023 DME data shows 11 claims. Open Payments data shows 1 records totaling $149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,596 and ending at $3,178. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	220	1,613	$120,791
2016	240	1,591	$120,610
2017	288	1,665	$120,329
2018	271	1,745	$143,873
2019	248	1,252	$106,024
2020	272	1,504	$141,241
2021	282	1,572	$141,154
2022	252	1,483	$131,701
2023	237	1,432	$125,994
2024	226	1,392	$105,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	75	211	$7,596
2016	64	161	$8,108
2017	61	135	$5,030
2018	72	206	$7,752
2019	58	162	$6,740
2020	65	204	$7,159
2021	55	193	$5,598
2022	62	238	$8,779
2023	65	236	$7,259
2024	53	159	$3,178

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	18	$199,101
2023	N/R	11	$131,502
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	77	247	$137
77334	Design and construction of complex radiation treatment device	64	140	$44
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	141	221	$42
77300	Calculation of radiation therapy dose	64	211	$24
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	123	190	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	30	1,890	$455
Venlafaxine Hcl	Venlafaxine Hcl	12	360	$258
Silver Sulfadiazine	Silver Sulfadiazine	14	370	$110
Trazodone Hcl	Trazodone Hcl	11	330	$27
Sertraline Hcl	Sertraline Hcl	12	360	$6

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$149	Novocure Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alireza Mirmiran, MD?

Tedicare shows public-source Medicare data for Alireza Mirmiran, MD (NPI 1801930441), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alireza Mirmiran, MD have ACO affiliation data?

Alireza Mirmiran, MD is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Alireza Mirmiran, MD?

Alireza Mirmiran, MD is linked to NEBRASKA METHODIST HOSPITAL (billing NPI 1689628372) in the available physician profile data.

Does Alireza Mirmiran, MD have Open Payments data?

Alireza Mirmiran, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.